Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 4396

BillFederalHouseIn Committee
Uterine Cancer Study Act of 2025
About This Bill
Committee
Latest Action · July 15, 2025
Referred to the House Committee on Energy and Commerce.
Congress
119th (2025–2027)
Introduced
July 15, 2025
Cosponsors (38)
38D 0R
View PDF ↗

Summary

Highlight any text to annotate
This bill directs the Secretary of Health and Human Services to conduct a comprehensive study on whether chemical hair straighteners are linked to uterine cancer, with special attention to higher rates of the disease among women of color. The study, which will be conducted in coordination with the Food and Drug Administration and National Institutes of Health, will review existing research, examine different types of hair straightening products (including those with dyes, bleach, and perms), and determine whether additional safety testing requirements should be imposed on manufacturers. The department must submit a methodology plan to Congress within 45 days, begin the study within 180 days of the bill's enactment, and deliver a final report within two years. This legislation aims to address potential health risks from widely used beauty products while ensuring the safety of consumers across all racial and ethnic backgrounds.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.